Wenbin Lin
31Patents
5h-index
37Co-inventors
69Inventor score
Filing activity: Mar 24, 2003 → Jul 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10206871B2 | Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof | Performing Operations; Transporting | 40 | Active |
| US9693957B2 | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders | Human Necessities | 26 | Active |
| US6878838B2 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | Chemistry; Metallurgy | 12 | Expired |
| US10517822B2 | Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers | Chemistry; Metallurgy | 6 | Active |
| US10780045B2 | Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof | Performing Operations; Transporting | 6 | Active |
| US10118169B2 | Chiral ligand-based metal-organic frameworks for broad-scope asymmetric catalysis | Emerging Cross-Sectional Technologies | 5 | Active |
| US11246877B2 | Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof | Chemistry; Metallurgy | 4 | Active |
| US10806694B2 | Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof | Performing Operations; Transporting | 4 | Active |
| US10133032B2 | Optical imaging lens | Physics | 4 | Active |
| US11389422B2 | Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy | Human Necessities | 3 | Active |
| US10953393B2 | Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations | Emerging Cross-Sectional Technologies | 3 | Active |
| US10596116B2 | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders | Human Necessities | 3 | Active |
| US10647733B2 | Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations | Emerging Cross-Sectional Technologies | 2 | Active |
| US11460677B2 | Optical imaging lens | Physics | 1 | Active |
| US10133031B2 | Optical imaging lens | Physics | 1 | Active |
| US10989899B2 | Optical imaging lens | Physics | 1 | Active |
| US9597658B2 | Metal-organic framework templated synthesis of porous inorganic materials as novel sorbents | Chemistry; Metallurgy | 1 | Active |
| US10302912B2 | Optical imaging lens | Electricity | 0 | Active |
| US9869842B2 | Imaging lens and electronic apparatus including the same | Physics | 0 | Active |
| US11740434B2 | Optical imaging lens | Physics | 0 | Active |
| US12048682B2 | Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy | Human Necessities | 0 | Active |
| US12124110B2 | Optical imaging lens | Physics | 0 | Active |
| US11673125B2 | Metal oxide-supported earth-abundant metal catalysts for highly efficient organic transformations | Emerging Cross-Sectional Technologies | 0 | Active |
| US10698175B2 | Optical imaging lens | General | 0 | Revoked |
| US11555985B2 | Optical imaging lens | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.